{
    "organizations": [],
    "uuid": "27f0ae729fad7f002d7e29d3f24aa7898528c3e2",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/05/15/pr-newswire-nordic-nanovector-asa-invitation-to-first-quarter-2018-results-presentation-and-webcast.html",
    "ord_in_thread": 0,
    "title": "Nordic Nanovector ASA: Invitation to First Quarter 2018 Results Presentation and Webcast",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "OSLO, Norway, May 16, 2018 /PRNewswire/ --\nNordic Nanovector ASA (OSE: NANO) announces its first quarter 2018 results on Wednesday, 30 May 2018.\nFirst Quarter 2018 Results Presentation and Webcast\nA presentation by Nordic Nanovector's senior management team will take place at 8:30 am CEST on 30 May at:\nThon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo\nMeeting Room: NYLAND\nThe presentation will be recorded as a webcast and will be available at www.nordicnanovector.com in the section: Investors & Media\nThe results report and the presentation will be available at www.nordicnanovector.com in the section: Investors & Media/Reports and Presentation/Interim Reports/2018 from 7:00 am CEST the same day.\nResults presentation in Norwegian\nAs announced in April, a separate presentation of the results in Norwegian, to be hosted by Nordic Nanovector's CFO and Interim CEO, and its VP IR & Corporate Communications, will take place on Thursday, 31 May 2018 at 8:30 am CEST at:\nThon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo\nMeeting Room: VIPPETANGEN\nTo attend the meeting please email - ir@nordicnanovector.com\nThe presentation will NOT be recorded as a webcast\nFor further information, please contact:\nIR enquiries\nMalene Brondberg,\nVP Investor Relations and Corporate Communications\nCell: +44-7561-431-762\nEmail: ir@nordicnanovector.com\nInternational Media Enquiries\nMark Swallow/David Dible/Isabelle Andrews (Citigate Dewe Rogerson)\nTel: +44-207-638-9571\nEmail: nordicnanovector@citigatedewerogerson.com\nAbout Nordic Nanovector\nNordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers.\nNordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting antibody-radionuclide-conjugate designed to advance the treatment of non-Hodgkin's lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets.\nFurther information about the Company can be found at www.nordicnanovector.com\nThis information was brought to you by Cision http://news.cision.com\nhttp://news.cision.com/nordic-nanovector/r/nordic-nanovector-asa--invitation-to-first-quarter-2018-results-presentation-and-webcast,c2521534\nView original content: http://www.prnewswire.com/news-releases/nordic-nanovector-asa-invitation-to-first-quarter-2018-results-presentation-and-webcast-300649215.html\nSOURCE Nordic Nanovector",
    "published": "2018-05-16T06:42:00.000+03:00",
    "crawled": "2018-05-16T17:11:53.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "oslo",
        "norway",
        "may",
        "nordic",
        "nanovector",
        "asa",
        "ose",
        "nano",
        "announces",
        "first",
        "quarter",
        "result",
        "wednesday",
        "may",
        "first",
        "quarter",
        "result",
        "presentation",
        "webcast",
        "presentation",
        "nordic",
        "nanovector",
        "senior",
        "management",
        "team",
        "take",
        "place",
        "cest",
        "may",
        "thon",
        "hotel",
        "vika",
        "atrium",
        "munkedamsveien",
        "oslo",
        "meeting",
        "room",
        "nyland",
        "presentation",
        "recorded",
        "webcast",
        "available",
        "section",
        "investor",
        "medium",
        "result",
        "report",
        "presentation",
        "available",
        "section",
        "investor",
        "cest",
        "day",
        "result",
        "presentation",
        "norwegian",
        "announced",
        "april",
        "separate",
        "presentation",
        "result",
        "norwegian",
        "hosted",
        "nordic",
        "nanovector",
        "cfo",
        "interim",
        "ceo",
        "vp",
        "ir",
        "corporate",
        "communication",
        "take",
        "place",
        "thursday",
        "may",
        "cest",
        "thon",
        "hotel",
        "vika",
        "atrium",
        "munkedamsveien",
        "oslo",
        "meeting",
        "room",
        "vippetangen",
        "attend",
        "meeting",
        "please",
        "email",
        "ir",
        "presentation",
        "recorded",
        "webcast",
        "information",
        "please",
        "contact",
        "ir",
        "enquiry",
        "malene",
        "brondberg",
        "vp",
        "investor",
        "relation",
        "corporate",
        "communication",
        "cell",
        "email",
        "ir",
        "international",
        "medium",
        "enquiry",
        "mark",
        "andrew",
        "citigate",
        "dewe",
        "rogerson",
        "tel",
        "email",
        "nordicnanovector",
        "nordic",
        "nanovector",
        "nordic",
        "nanovector",
        "committed",
        "develop",
        "deliver",
        "innovative",
        "therapy",
        "patient",
        "address",
        "major",
        "unmet",
        "medical",
        "need",
        "advance",
        "cancer",
        "care",
        "company",
        "aspires",
        "become",
        "leader",
        "development",
        "targeted",
        "therapy",
        "haematological",
        "cancer",
        "nordic",
        "nanovector",
        "lead",
        "candidate",
        "novel",
        "designed",
        "advance",
        "treatment",
        "lymphoma",
        "nhl",
        "nhl",
        "indication",
        "substantial",
        "unmet",
        "medical",
        "need",
        "representing",
        "growing",
        "market",
        "forecast",
        "worth",
        "nearly",
        "usd",
        "billion",
        "nordic",
        "nanovector",
        "intends",
        "retain",
        "marketing",
        "right",
        "actively",
        "participate",
        "commercialisation",
        "core",
        "market",
        "information",
        "company",
        "found",
        "information",
        "brought",
        "cision",
        "http",
        "http",
        "c2521534",
        "view",
        "original",
        "content",
        "http",
        "source",
        "nordic",
        "nanovector"
    ]
}